Core C: IgSeq and NGS Core

核心 C:IgSeq 和 NGS 核心

基本信息

  • 批准号:
    10549607
  • 负责人:
  • 金额:
    $ 36.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-08-01 至 2028-03-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT A principal goal of the Program Project is to chart the changes in influenza antibody repertoire following vaccination or infection and to build on those results to direct immunogen design efforts. Core C, the Ig-Seq and NGS Core, will serve the overall goals of the Program Project by providing high-throughput antibody repertoire profiling services. Specifically, it will provide in-depth NextGen Sequencing (NGS) of antibody transcripts from B cells (BCR-Seq) and quantitative high-resolution proteomic analysis of serum antibody molecules (Ig-Seq). From these sequence analyses, the Core will generate full-length antibody sequences for recombinant expression and characterizations as monoclonal antibodies.The Core will also serve all Projects and Cores of the Program Project by providing a centralized data repository, management of all antibody sequence data, robust and consistent data analysis. The specific aims of Core C are: (1) provide the NGS service to define the B cell repertoire; (2) provide the proteomic-based antibody analysis service to define serum antibody repertoire; (3) provide a centralized data repository and analysis for antibody sequences generated by all the Projects and Cores; and (4) expand and optimize the provided services. The Ig-Seq and NGS Core is critical for the success of the Program Project, offering high-throughput tools for deep and comprehensive monitoring of changes in three distinct components of antibody repertoires: serum antibody molecules, memory B cells, and plasmablasts.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jiwon Lee其他文献

Jiwon Lee的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jiwon Lee', 18)}}的其他基金

Understanding Early-life Influenza Antibody Repertoire Imprinting Through Infection or Vaccination
了解生命早期流感抗体库通过感染或疫苗印记
  • 批准号:
    10215742
  • 财政年份:
    2019
  • 资助金额:
    $ 36.36万
  • 项目类别:
Understanding the impact of imprinted serum antibody repertoire on subsequent vaccine responses
了解印迹血清抗体库对后续疫苗反应的影响
  • 批准号:
    10271749
  • 财政年份:
    2016
  • 资助金额:
    $ 36.36万
  • 项目类别:
Understanding the impact of imprinted serum antibody repertoire on subsequent vaccine responses
了解印迹血清抗体库对后续疫苗反应的影响
  • 批准号:
    10460275
  • 财政年份:
    2016
  • 资助金额:
    $ 36.36万
  • 项目类别:
Understanding the impact of imprinted serum antibody repertoire on subsequent vaccine responses
了解印迹血清抗体库对后续疫苗反应的影响
  • 批准号:
    10647708
  • 财政年份:
    2016
  • 资助金额:
    $ 36.36万
  • 项目类别:

相似海外基金

The evolution of dengue virus-reactive circulating antibody repertoire
登革热病毒反应性循环抗体库的进化
  • 批准号:
    10647572
  • 财政年份:
    2023
  • 资助金额:
    $ 36.36万
  • 项目类别:
Antibody repertoire characterization in the context of coronaviruses
冠状病毒背景下的抗体库表征
  • 批准号:
    10266227
  • 财政年份:
    2020
  • 资助金额:
    $ 36.36万
  • 项目类别:
The Anti-Cyclic Citrullinated Protein Antibody Repertoire and Lung Involvement in Rheumatoid Arthritis
类风湿性关节炎中的抗环瓜氨酸蛋白抗体库和肺参与
  • 批准号:
    10252749
  • 财政年份:
    2020
  • 资助金额:
    $ 36.36万
  • 项目类别:
Molecular analysis of antibody repertoire elicited after yellow fever vaccination
黄热病疫苗接种后产生的抗体库的分子分析
  • 批准号:
    10401404
  • 财政年份:
    2019
  • 资助金额:
    $ 36.36万
  • 项目类别:
Functional Antibody Repertoire Against S. aureus Leukocidins after Invasive Human Infection
人类侵袭性感染后针对金黄色葡萄球菌杀白细胞素的功能性抗体库
  • 批准号:
    10092085
  • 财政年份:
    2019
  • 资助金额:
    $ 36.36万
  • 项目类别:
Molecular analysis of antibody repertoire elicited after yellow fever vaccination
黄热病疫苗接种后产生的抗体库的分子分析
  • 批准号:
    10578848
  • 财政年份:
    2019
  • 资助金额:
    $ 36.36万
  • 项目类别:
Molecular analysis of antibody repertoire elicited after yellow fever vaccination
黄热病疫苗接种后产生的抗体库的分子分析
  • 批准号:
    9882945
  • 财政年份:
    2019
  • 资助金额:
    $ 36.36万
  • 项目类别:
Functional Antibody Repertoire Against S. aureus Leukocidins after Invasive Human Infection
人类侵袭性感染后针对金黄色葡萄球菌杀白细胞素的功能性抗体库
  • 批准号:
    10541163
  • 财政年份:
    2019
  • 资助金额:
    $ 36.36万
  • 项目类别:
Understanding Early-life Influenza Antibody Repertoire Imprinting Through Infection or Vaccination
了解生命早期流感抗体库通过感染或疫苗印记
  • 批准号:
    10215742
  • 财政年份:
    2019
  • 资助金额:
    $ 36.36万
  • 项目类别:
Functional Antibody Repertoire Against S. aureus Leukocidins after Invasive Human Infection
人类侵袭性感染后针对金黄色葡萄球菌杀白细胞素的功能性抗体库
  • 批准号:
    10326846
  • 财政年份:
    2019
  • 资助金额:
    $ 36.36万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了